ABSTRACT The effectiveness of three bradyeardiac drugs for increasing distal coronary perfusion pressure and decreasing stenosis resistance (SR) in partially occluded vessels, and thereby for increasing collateral blood flow and segmental function (%SS) in an occluded area dependent on the stenotic vessel, was studied in anesthetized dogs. Initially, the distal portion of the left anterior descending (LAD) coronary artery was occluded followed by subsequent stenosis of the left circumflex (LC) coronary artery that supplies collateral flow to the ischemic LAD area. A decrease in LC flow (35 ± 3 to 24 + 3 ml/min) and distal coronary pressure (109 4 to 47 + 4 mm Hg) resulted in an increase in SR (0.03 ± 0.02 to 2.97 ± 0.53 U), and decreases in LC %SS (9.3 + 1.1% to 1.9 ± 2.0%), subendocardial blood flow (1.11 + 0.06 to 0.43 + 0.05 ml/min/g), and LAD collateral flow (0.36 + 0.11 to 0.22 ± 0.05 ml/min/g). Upon intravenous administration of the fl-receptor-blocking drug sotalol (0.3 mg/kg) or metoprolol (0. 1 mg/kg) and the non-,f-blocking bradycardiac drug N-dimethylpropranolol (5.0 mg/kg) in doses that produced similar decreases in heart rate (30 to 40 beats/min), distal coronary pressure, subendocardial blood flow, and %SS in the LC area were markedly improved. SR was significantly reduced (2.97 + 0.53 to 1.66 + 0.37 U). The improvement in %SS of the LC area was highly correlated (r = .93, p < .001) with the increase in subendocardial blood flow. Cardiac pacing to the control heart rate partially attenuated the beneficial actions of the three drugs in the LC region. In spite of the increase in LC distal pressure, collateral flow to the LAD region was increased significantly only by N-dimethylpropranolol. %SS in the LAD area was not improved by any of the drugs studied. These results suggest that in spite of a significant increase in coronary pressure distal to a stenosis, collateral flow is minimally affected by fl-receptor blockade. In 
RESULTS of numerous studies have demonstrated "'coronary steal" after administration of vasodilating drugs that primarily dilate small coronary resistance vessels.'-' Coronary steal has been shown to occur in the presence of a single-vessel occlusion' or in experimental preparations in which one coronary artery is totally occluded and another vessel partially constricted.4'' The mechanism for this phenomenon is thought to be the result of a pressure drop that occurs across the large epicardial coronary artery proximal to the origin of the collateral vessels supplying the oc-eluded area. If the vessel of origin of the collaterals is not partially obstructed, the decrease in collateral flow after arteriolar vasodilation would be less since the pressure drop between the left main coronary artery and the origin of the collaterals would be small and large arterial resistance is only approximately 12% of the total resting resistance of a main coronary artery.'
A "reverse coronary steal" has also been shown to occur after the administration of methoxamine, an aadrenergic agonist, to dogs with acute coronary occlusions. 6 It was concluded that methoxamine-induced vasoconstriction of vessels in the nonischemic area would shunt collateral flow to the ischemic region.6
This phenomenon has not been studied in an animal preparation of multivessel occlusion in which one coronary artery supplying collateral flow to a region distal to a total coronary occlusion has a significant coronary arterial stenosis.
In a recent study in our laboratory7 we found that /3-receptor blockade produced an increase in pressure distal to a stenosis of a left circumflex coronary artery (LC) that resulted in an increase in subendocardial blood flow to the ischemic myocardium and a decrease in the dynamic severity of the coronary arterial stenosis. In the present study two /3-receptor-blocking drugs, sotalol and metoprolol, and the non-,3-blocking bradycardiac drug N-dimethylpropranolol8 were administered to dogs with a severe LC stenosis in addition to a left anterior descending coronary arterial (LAD) occlusion to determine if an increase in perfusion pressure distal to the stenosis and decrease in stenosis resistance (SR) might result in an increase in collateral blood flow to the adjacent area distal to the total occlusion. In addition, piezoelectric crystals were placed in the partially and totally occluded areas to monitor myocardial function before and after pharmacologic intervention. The importance of changes in heart rate produced by the three bradycardiac drugs was also determined.
Methods
Experimental preparation. Adult To prevent platelet aggregation, the dogs were treated with aspirin (30 mg/kg iv) before LAD occlusion and LC stenosis.7 Intravenous heparin, 500 U/kg, was also administered. The electrocardiogram (ECG) (limb lead II), phasic and mean aortic blood pressures, left ventricular systolic and end-diastolic pressures, dP/dt, phasic and mean coronary perfusion pressures, retrograde coronary pressure, myocardial segment lengths, and phasic and mean LC coronary blood flows were continuously monitored on a polygraph (Grass Model 7).
Regional myocardial blood flow. The distribution of coronary blood flow was determined with the radioactive microsphere technique. Carbonized plastic microspheres (15 + 3 ,um in diameter, New England Nuclear Company) labeled with 14'Ce, 5'Cr, '03Ru, and 95Nb were obtained as 2 mCi of nuclide in 10 ml of isotonic saline, to which one drop of Tween 80 was added to minimize aggregation. The mixture was agitated before injection in a vortex mixer (Cole-Parmer 4722) for 15 min. Approximately 2 to 4 X 106 microspheres were injected into the left atrium in a total volume of 0.75 to 1.0 ml, followed by an 8 ml saline (370 C) wash. A few seconds before each microsphere injection a timed collection of reference flow from the femoral artery was started and maintained at a constant rate (6.5 ml/min) for 3 min.
Experimental protocol. In all groups the preparation was allowed to stabilize for 30 min after surgery before preocclusion hemodynamic measurements were made. Subsequently, the distal LAD was ligated, a 30 min stabilization period was allowed, and the first radioactive microsphere was administered (control LAD occlusion). Previous results from our laboratory2 have shown that collateral flow is stable from 5 min to 2 hr after LAD occlusion; thus, we could be certain that drug effects would be easily recognized. A stenosis of the LC sufficient to reduce resting coronary blood flow and distal coronary perfusion pressure approximately 40% to 60% was then produced by adjustment of the mechanical occluder. After a 15 to 20 min stabilization period the second radioactive microsphere was given (LAD occlusion and LC stenosis). We have demonstrated that perfusion distal to a stenosis of this severity is stable for at least 1 hr.7 Sotalol (0.3 mg/kg), metoprolol (0. 1 mg/kg), or N-dimethylpropranolol (5.0 mg/kg) were then administered intravenously over 5 min and the preparation was allowed to reach a steady state for approximately 20 min before the third microsphere was administered. Doses of drugs were chosen that produced nearly equivalent decreases in heart rate (30 to 40 beats/ min), as determined in previous studies in our laboratory.7 8 Adequacy of /3-blockade was tested by intravenous administration of isoproterenol (0.3 ,ug/kg iv). Finally, heart rate was returned to the predrug level by left atrial pacing and the fourth microsphere was given. Three experimental groups of seven dogs each were studied.
Analysis of left ventricular tissue samples. After completion of the experiment, the LC was ligated and, to differentiate areas of myocardium subjected to occlusion and stenosis, respectively, India ink and Patent blue dye were injected distal to the ligation sites of the LC and LAD at the time when the mean arterial blood pressure of each dog was reached. Nonischemic areas remained unstained. The hearts were excised, washed with saline, and fixed in 10% formalin for 24 hr. The left ventricle was sectioned into base, middle, and apex of both anterior (area perfused by the LAD) and posterior (area perfused by the LC) regions. Samples were only obtained from the center of the dyed regions to avoid possible contamination from overlapping circulations. 1 These samples were subdivided into subepicardial (outer), midmyocardial (middle), and subendocardial (inner) layers of approximately equal weight (1 to 2 g). All tissue samples were weighed and placed in glass scintillation vials, and the activity of the isotopes in each tissue sample was determined at four energy windows in an Autogamma spectrometer (Searle Analytic 1195). The activity of each isotope in the reference blood flow sample was determined in a similar manner. Myocardial blood flow in the tissue samples was calculated as described elsewhere.7 The tissue areas of the base, middle, and apex were pooled for calculation of blood flow in the subepicardium and subendocardium of the normal, partially ischemic (LC), and ischemic (LAD) regions. Transmural blood flow was the weighted average obtained from the subepicardium, midmyocardium, and subendocardium of each region sampled.
Calculation of resistances. SR was calculated by dividing the difference between the aortic and distal coronary arterial pressures by coronary blood flow at end-diastole.7 Distal coronary vascular resistance was calculated by dividing the peripheral coronary arterial pressure by coronary blood flow at enddiastole.
Data analysis. Transmural distribution of coronary blood flow was expressed as the ratio of counts per gram subendocardiLim to counts per gram subepicardium (endo/epi ratio). Tissue blood flow was expressed in milliliters per minute per gram.
TABLE 1
Statistical analysis within groups was made by analysis of variance. Individual comparisons between preocclusion, occlusion, occlusion and stenosis, drug, and drug plus pacing were performed by use of Dunnet's procedure. Linear regression analysis was also used to determine correlations between certain hemodynamic variables. Differences were considered significant when p < .05. Values are mean + SEM.
Results
Hemodynamic effects of the three bradycardiac drugs are summarized in table 1 and figure 1. All three drugs produced similar qualitative and quantitative changes in hemodynamics and %SS (no difference by analysis of variance) and are treated as one group in the following discussion. Changes in myocardial perfusion induced by each drug are reported separately. Coronary arterial stenosis of the LC in the presence of an LAD occlusion produced a significant decrease in mean peripheral coronary pressure (63 ± 4 mm Hg), LC blood flow (35 + 3 to 24 ± 3 ml/min), and distal resistance (3.37 ± 0.30 to 2.18 ± 0.14 U) and an increase in SR (0.03 ±(0.02 to 2.97 ± 0.53 U; figure   1 ). Administration of sotalol, metoprolol, or N-dimethylpropranolol resulted in a significant decrease in heart rate and dP/dt. Mean peripheral coronary pressure distal to the LC stenosis was increased by all three compounds. This rise in distal pressure was secondary to a significant increase in distal resistance (2.18 + 0.53 and 3.14 + 0.46 U). After left atrial pacing to the predrug heart rate, dP/dt and SR remained reduced, but distal resistance was decreased to the predrug level (3.14 ± 0.46 to 2.42 ± 0.12 U). Myocardial figure 2 .
In nine experiments (n 3 in each group) the three drugs produced small but significant decreases in %SS in the normal myocardium (12.5 + 1.1% to 11.3 0.9%).
Regional Relationship between regional blood flow and function.
The relationship between myocardial blood flows in the subepicardium, midmyocardium, and subendocardium in the LC region and %SS is illustrated in figure  3 . There was an excellent correlation (r = .93, p < .01) between subendocardial blood flow and %SS, as TABLE 5 Effect of N dimethylpropranolol (5.0 mg/kg iv) on regional myocardial blood flow (ml/min/g) measured by the subendocardial crystals. Similarly, a close relationship was also observed between midmyocardial flow and %SS (r = .77, p < .01), but no correlation was observed between subepicardial flow and %SS (r = .19, p < .1).
Discussion
The results of this study indicate that increases in perfusion pressure distal to a coronary arterial stenosis induced by /3-receptor-blocking drugs do not produce an increase in blood flow to a collateral-dependent region subjected to a total coronary occlusion, i.e., a reverse coronary steal. However, a similar increase in distal pressure produced by the non-/3-blocking bradycardiac drug N-dimethylpropranolol resulted in a significant increase in collateral perfusion. All three drugs had similar hemodynamic effects that resulted in marked improvements in subendocardial blood flow, SR, and %SS in the partially ischemic area. Cardiac pacing to the predrug rate partially attenuated these beneficial actions.
Our results with the nonselective /,3-and /32-receptor blocker sotalol, the cardioselective drug metoprolol, and the bradycardiac drug N-dimethylpropranolol, which demonstrate that a favorable redistribution of blood flow occurs to the subendocardium in a partially ischemic region distal to a stenosis, are in agreement with previous results from this laboratory.7' 8 All three drugs produced similar increases in endo/epi, which indicates that /3-receptor blockade is not essential for this beneficial action. Recent work of Schamhardt et al. 1 On the other hand, contraction in peripheral regions within the perfusion territory of the totally occluded area may be improved by drug therapy. '4 An excellent linear correlation (r = .93) was found between blood flow to the subendocardium and %SS in the partially ischemic area. Midmyocardial flow also showed a significant correlation (r = .77) to segment function, but no relationship was observed between shortening and subepicardial perfusion. It is not surprising that subendocardial flow and function correlated closely since %SS in both subepicardium and subendocardium have been shown to be tightly tethered to subendocardial perfusion in the presence of a coronary arterial stenosis of a severity similar to that produced in the present study if the crystals are oriented circumferentially (parallel to the short axis of the heart). 16 Although coronary steal has been well documented, 1-1 the occurrence of the reverse phenomenon is less well established.6 Since collateral blood flow has been shown to be dependent on aortic blood pressure, 17 particularly aortic diastolic pressure and heart rate or time spent in diastole,'8 it was hypothesized that stenosis of the LC coronary artery supplying blood flow to the occluded LAD region should result in a decrease in distal coronary pressure with a concomitant reduction in collateral flow. Conversely, an increase in distal coronary pressure and diastolic perfusion time produced by the three bradycardiac drugs should produce an increase in collateral flow. Coronary arterial stenosis was found to produce the expected decrease in distal perfusion pressure and collateral flow, but only N-dimethylpropranolol produced the expected increase in collateral flow in spite of similar increases in distal coronary pressure and decreases in heart rate 398 observed after all three bradycardiac drugs. The reasons for the differences among these compounds are not clear but may be related to a number of factors that include effects of blockade of , 3- Another potential problem that might help explain the lack of effect of /3-blockade on collateral blood flow or differences between drugs relates to errors in distinguishing true collateral flow from overlap flow."' 23 It is possible that tissue samples from the distal LAD central ischemic zone might be contaminated with overlap flow from the adjacent LC or proximal LAD and this might result in erroneous calculations of collateral flow. In a recent study23 we found that overlap flow is minimal if samples are taken from the center of the dyed ischemic area, as was done in the present study. In addition, results of preliminary studies from this laboratory indicate that propranolol, sotalol, and N-dimethylpropranolol have no effect on collateral perfusion in a single LAD occlusion preparation in the absence of a stenosis when overlap flow has been accounted for.
Although all three drugs may have produced small increases in collateral flow through channels arising distal to the LC stenosis, it is possible that small de-creases were observed via collaterals arising proximal to the stenosis of the LC, the proximal LAD, or the right coronary artery. Since small decreases in aortic pressure occurred after administration of these compounds, the overall effect on collateral flow to the LAD would be the sum total of opposing actions that might help explain the varying drug effects observed. 3 Another possibility is that the increase in distal perfusion pressure produced by the drugs was not sufficient (21 mm Hg) to accurately measure a consistent increase in collateral flow. LC stenosis produced a much larger change (63 mm Hg decrease) in distal pressure, so that consistent changes in collateral flow were perhaps more easily observed. In addition, collateral flow may not be linearly related to aortic or distal coronary pressure over a wide range of pressures."
Because of the effects of anesthesia and species differences these results cannot be directly extrapolated to man, but the present findings indicate that bradycardiac drugs may produce marked improvements in blood flow and %SS distal to a partial coronary occlusion as well as decrease the hemodynamic severity of a noncircumferential coronary arterial stenosis. This improvement in the oxygen supply-demand imbalance in a partially ischemic region resulted in an increase in collateral flow to an adjacent region distal to a total occlusion in the presence of the non-fl-blocker N-dimethylpropranolol. This suggests that bradycardiac drugs that lack fl-blocking activity may have certain advantages over fl-antagonists in the treatment of ischemic heart disease.
